The LGL Group Reports Third Quarter 2021 Results
The LGL Group, Inc. reported financial results for Q3 and YTD 2021, revealing a revenue decrease to $7.5 million from $8.1 million in Q3 2020, and $20.9 million for the nine months compared to $23.7 million the prior year. A backlog improvement to $21.8 million was noted. Net income soared to $31.8 million, largely due to a $40.4 million gain from SPAC investments. Meanwhile, diluted EPS rose to $5.97. Strategic plans include a spin-off of the MTronPTI subsidiary to enhance shareholder value.
- Net income increased significantly to $31.8 million from $0.6 million year-over-year.
- Diluted earnings per share rose to $5.97 from $0.12 in the prior year quarter.
- Backlog improved to $21.8 million, indicating potential future revenue growth.
- Operating revenues decreased to $7.5 million, representing a 7.1% decline year-over-year.
- Adjusted EBITDA fell to $0.7 million from $0.9 million in Q3 2020.
- Continued supply chain and workforce constraints affecting operations.
-
Operating revenues declined to
from$7.5 million for the prior year quarter, and declined to$8.1 million for the nine months ended$20.9 million September 30, 2021 compared to for the prior year nine months$23.7 million - Business units of Avionics and Defense continue to gain traction from Pre-Covid levels while cost push inflationary pressures remain prevalent throughout the operations
-
Backlog improvement of
versus$21.8 million at$19.8 million December 31, 2020 and at$21.5 million September 30, 2020 -
Net cash position, including marketable securities, of
($66.4 million of which are IRNT common stock and warrant holdings)$44.4 million -
Income before income taxes of
compared to$40.8 million included$0.8 million as a result of one-time transactions related to the Company’s$40.3 million SPAC investment -
Net income of
compared to last year’s earnings of$31.8 million $0.6 million -
Diluted net income per share of
compared to$5.97 per share for the prior year quarter$0.12 -
Adjusted EBITDA was
compared to$0.7 million for Q3 2020 and$0.9 million compared to$1.7 million for Q3YTD 2020$2.0 million
RESULTS FROM OPERATIONS
Revenues from operations were
Gross margins were
Excluding the
“For analytical purposes, LGL’s ‘bottom-line’ will be fairly difficult to interpret this quarter. As a result of the GAAP requirement that we value stock price changes from our equity investments and flow that through the income statement to net income, investors should expect that large swings in our quarterly GAAP earnings will continue.” said
Net income was
Quarterly adjusted EBITDA, a non-GAAP measure, was
For the period ending
On
As of
“Investors should be aware that gyrations in reported net income of this magnitude obfuscate the numbers describing the operating performance of the business” The Company’s President and Chief Executive Officer,
The Company’s deferred tax assets related to net operating loss and tax credit carryforwards of approximately
STRATEGIC INITIATIVES:
The board has previously approved a spin-off of the MTronPTI subsidiary, which will be submitted to a shareholder vote for approval. The Company continues to strive for profitable growth internally and by acquisition. LGL believes that spin-off would enable shareholders to more clearly evaluate the performance and future potential of each entity on a standalone basis, while allowing each to pursue its own distinct business strategy and capital allocation policy. Separating MTronPTI as an independent, publicly owned company positions the business to increase value to both
The Company continues to explore growth organically and through diversified mergers and acquisitions and believes the relationship with the
BALANCE SHEET
The Company’s strong balance sheet reflects a net cash position, including marketable securities, of
About
Headquartered in
For more information on the Company and its products and services, contact
Caution Concerning Forward Looking Statements
This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. These forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to us and our current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans, anticipated actions and our future financial condition and results. Certain of these risks and uncertainties are described in greater detail in our filings with the
|
||||||||
Condensed Consolidated Statements of Operations |
||||||||
(Unaudited) |
||||||||
(Dollars in Thousands, Except Share and Per Share Amounts) |
||||||||
|
|
For the Three Months Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
REVENUES |
|
$ |
7,501 |
|
|
$ |
8,071 |
|
Costs and expenses: |
|
|
|
|
|
|
|
|
Manufacturing cost of sales |
|
|
4,782 |
|
|
|
5,203 |
|
Engineering, selling and administrative |
|
|
3,465 |
|
|
|
2,159 |
|
OPERATING (LOSS) INCOME |
|
|
(746 |
) |
|
|
709 |
|
Gain (loss) on equity investment in unconsolidated subsidiary |
|
|
60,205 |
|
|
|
(61 |
) |
Unrealized (loss) gain on marketable securities |
|
|
(18,867 |
) |
|
|
122 |
|
Other income (expense), net |
|
|
237 |
|
|
|
30 |
|
INCOME BEFORE INCOME TAXES |
|
|
40,829 |
|
|
|
800 |
|
Income tax expense |
|
|
9,049 |
|
|
|
171 |
|
NET INCOME |
|
$ |
31,780 |
|
|
$ |
629 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in basic EPS calculation |
|
|
5,273,786 |
|
|
|
5,212,652 |
|
BASIC NET INCOME PER COMMON SHARE |
|
$ |
6.03 |
|
|
$ |
0.12 |
|
Weighted average number of shares used in diluted EPS calculation |
|
|
5,325,815 |
|
|
|
5,251,078 |
|
DILUTED NET INCOME PER COMMON SHARE |
|
$ |
5.97 |
|
|
$ |
0.12 |
|
|
|
For the Nine Months Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
REVENUES |
|
$ |
20,919 |
|
|
$ |
23,748 |
|
Costs and expenses: |
|
|
|
|
|
|
|
|
Manufacturing cost of sales |
|
|
13,334 |
|
|
|
15,681 |
|
Engineering, selling and administrative |
|
|
7,775 |
|
|
|
6,514 |
|
OPERATING (LOSS) INCOME |
|
|
(190 |
) |
|
|
1,553 |
|
Gain (loss) on equity investment in unconsolidated subsidiary |
|
|
59,453 |
|
|
|
(200 |
) |
Unrealized (loss) gain on marketable securities |
|
|
(18,665 |
) |
|
|
15 |
|
Other income (expense), net |
|
|
271 |
|
|
|
(19 |
) |
INCOME BEFORE INCOME TAXES |
|
|
40,869 |
|
|
|
1,349 |
|
Income tax expense |
|
|
9,080 |
|
|
|
282 |
|
NET INCOME |
|
$ |
31,789 |
|
|
$ |
1,067 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in basic EPS calculation |
|
|
5,273,263 |
|
|
|
5,159,452 |
|
BASIC NET INCOME PER COMMON SHARE |
|
$ |
6.03 |
|
|
$ |
0.21 |
|
Weighted average number of shares used in diluted EPS calculation |
|
|
5,334,534 |
|
|
|
5,195,754 |
|
DILUTED NET INCOME PER COMMON SHARE |
|
$ |
5.96 |
|
|
$ |
0.21 |
|
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(Unaudited) |
||||||||
(Dollars in Thousands) |
||||||||
|
|
2021 |
|
|
2020 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
15,593 |
|
|
$ |
18,331 |
|
Marketable securities |
|
|
50,828 |
|
|
|
5,791 |
|
Accounts receivable, net |
|
|
5,031 |
|
|
|
4,122 |
|
Inventories, net |
|
|
5,260 |
|
|
|
5,280 |
|
Prepaid expenses and other current assets |
|
|
414 |
|
|
|
257 |
|
Total Current Assets |
|
|
77,126 |
|
|
|
33,781 |
|
Property, plant and equipment, net |
|
|
3,183 |
|
|
|
2,785 |
|
Right-of-use lease assets |
|
|
324 |
|
|
|
422 |
|
Equity investment in unconsolidated subsidiary |
|
|
- |
|
|
|
3,072 |
|
Intangible assets, net |
|
|
271 |
|
|
|
327 |
|
Deferred income tax asset |
|
|
20 |
|
|
|
3,052 |
|
Other assets |
|
|
7 |
|
|
|
16 |
|
Total Assets |
|
$ |
80,931 |
|
|
$ |
43,455 |
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Total Current Liabilities |
|
$ |
2,956 |
|
|
$ |
3,397 |
|
Total Long-Term Liabilities |
|
|
6,274 |
|
|
|
293 |
|
Total Liabilities |
|
|
9,230 |
|
|
|
3,690 |
|
Total Stockholders' Equity |
|
|
71,701 |
|
|
|
39,765 |
|
Total Liabilities and Stockholders' Equity |
|
$ |
80,931 |
|
|
$ |
43,455 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliations of GAAP to Non-GAAP Measures
To supplement our consolidated financial statements presented on a GAAP (generally accepted accounting principles) basis, the Company uses certain non-GAAP measures, including Adjusted EBITDA, which we define as net income adjusted to exclude depreciation and amortization expense, interest income (expense), income taxes expense (benefit), stock-based compensation expense, investment income and loss, and other items we believe are discrete events which have a significant impact on comparable GAAP measures and could distort an evaluation of our normal operating performance. These adjustments to our GAAP results are made with the intent of providing both management and investors a more complete understanding of the underlying operational results and trends and our marketplace performance. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net earnings or diluted earnings per share prepared in accordance with generally accepted accounting principles in
Reconciliation of GAAP Net Income Before Income Taxes to Non-GAAP Adjusted EBITDA:
|
|
For the Three Months Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
(000's, except share and per share amounts) |
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
40,829 |
|
|
$ |
800 |
|
Interest expense, net |
|
|
3 |
|
|
|
3 |
|
Depreciation and amortization |
|
|
146 |
|
|
|
131 |
|
Non-cash stock compensation |
|
|
19 |
|
|
|
57 |
|
(Gain) loss on equity investment in unconsolidated subsidiary |
|
|
(60,205 |
) |
|
|
61 |
|
Investment loss (income) |
|
|
18,609 |
|
|
|
(124 |
) |
Non-cash donation of IRNT common stock |
|
|
1,318 |
|
|
|
— |
|
Adjusted EBITDA |
|
$ |
719 |
|
|
$ |
928 |
|
|
|
|
|
|
|
|
|
|
Basic per share information: |
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
5,273,786 |
|
|
|
5,212,652 |
|
Adjusted EBITDA per share |
|
$ |
0.14 |
|
|
$ |
0.18 |
|
|
|
|
|
|
|
|
|
|
Diluted per share information: |
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
5,325,815 |
|
|
|
5,251,078 |
|
Adjusted EBITDA per share |
|
$ |
0.14 |
|
|
$ |
0.18 |
|
|
|
For the Nine Months Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
(000's, except share and per share amounts) |
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
40,869 |
|
|
$ |
1,349 |
|
Interest expense, net |
|
|
9 |
|
|
|
7 |
|
Depreciation and amortization |
|
|
417 |
|
|
|
392 |
|
Non-cash stock compensation |
|
|
116 |
|
|
|
104 |
|
(Gain) loss on equity investment in unconsolidated subsidiary |
|
|
(59,453 |
) |
|
|
200 |
|
Investment loss (income) |
|
|
18,407 |
|
|
|
(67 |
) |
Non-cash donation of IRNT common stock |
|
|
1,318 |
|
|
|
— |
|
Adjusted EBITDA |
|
$ |
1,683 |
|
|
$ |
1,985 |
|
|
|
|
|
|
|
|
|
|
Basic per share information: |
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
5,273,263 |
|
|
|
5,159,452 |
|
Adjusted EBITDA per share |
|
$ |
0.32 |
|
|
$ |
0.38 |
|
|
|
|
|
|
|
|
|
|
Diluted per share information: |
|
|
|
|
|
|
|
|
Weighted average shares outstanding |
|
|
5,334,534 |
|
|
|
5,195,754 |
|
Adjusted EBITDA per share |
|
$ |
0.32 |
|
|
$ |
0.38 |
|
Reconciliations of GAAP to Non-GAAP Measures
The Non-GAAP statements have been prepared to exclude transactions associated with our investment in Sponsor (collectively the “Sponsor Transactions”). The Sponsor Transactions include: 1) the Company’s third quarter 2021
Reconciliation of GAAP Net Income Before Income Taxes to Non-GAAP Proforma without Sponsor Transactions:
|
|
GAAP |
|
|
Non-GAAP Adjustment for Sponsor Transactions |
|
|
Non-GAAP Proforma without Sponsor Transactions |
|
|
GAAP |
|
|
Non-GAAP Adjustment for Sponsor Transactions |
|
|
Non-GAAP Proforma without Sponsor Transactions |
|
||||||
|
|
For the Three Months Ended |
|
|
For the Three Months Ended |
|
||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||||||
REVENUES |
|
$ |
7,501 |
|
|
$ |
- |
|
|
$ |
7,501 |
|
|
$ |
8,071 |
|
|
$ |
- |
|
|
$ |
8,071 |
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manufacturing cost of sales |
|
|
4,782 |
|
|
|
— |
|
|
|
4,782 |
|
|
|
5,203 |
|
|
|
— |
|
|
|
5,203 |
|
Engineering, selling and administrative |
|
|
3,465 |
|
|
|
1,318 |
|
|
|
2,147 |
|
|
|
2,159 |
|
|
|
— |
|
|
|
2,159 |
|
OPERATING (LOSS) INCOME |
|
|
(746 |
) |
|
|
(1,318 |
) |
|
|
572 |
|
|
|
709 |
|
|
|
— |
|
|
|
709 |
|
Gain (loss) on equity investment in unconsolidated subsidiary |
|
|
60,205 |
|
|
|
60,205 |
|
|
|
— |
|
|
|
(61 |
) |
|
|
(61 |
) |
|
|
— |
|
Unrealized (loss) gain on marketable securities |
|
|
(18,867 |
) |
|
|
(18,839 |
) |
|
|
(28 |
) |
|
|
122 |
|
|
|
— |
|
|
|
122 |
|
Interest expense, net |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(3 |
) |
|
|
— |
|
|
|
(3 |
) |
Other income (expense), net |
|
|
237 |
|
|
|
258 |
|
|
|
(21 |
) |
|
|
33 |
|
|
|
— |
|
|
|
33 |
|
Income (loss) before income taxes |
|
$ |
40,829 |
|
|
$ |
40,306 |
|
|
$ |
523 |
|
|
$ |
800 |
|
|
$ |
(61 |
) |
|
$ |
861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended |
|
|
For the Nine Months Ended |
|
||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||||||
REVENUES |
|
$ |
20,919 |
|
|
$ |
- |
|
|
$ |
20,919 |
|
|
$ |
23,748 |
|
|
$ |
- |
|
|
$ |
23,748 |
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manufacturing cost of sales |
|
|
13,334 |
|
|
|
— |
|
|
|
13,334 |
|
|
|
15,681 |
|
|
|
— |
|
|
|
15,681 |
|
Engineering, selling and administrative |
|
|
7,775 |
|
|
|
1,318 |
|
|
|
6,457 |
|
|
|
6,514 |
|
|
|
— |
|
|
|
6,514 |
|
OPERATING (LOSS) INCOME |
|
|
(190 |
) |
|
|
(1,318 |
) |
|
|
1,128 |
|
|
|
1,553 |
|
|
|
— |
|
|
|
1,553 |
|
Gain (loss) on equity investment in unconsolidated subsidiary |
|
|
59,453 |
|
|
|
59,453 |
|
|
|
— |
|
|
|
(200 |
) |
|
|
(200 |
) |
|
|
— |
|
Unrealized (loss) gain on marketable securities |
|
|
(18,665 |
) |
|
|
(18,839 |
) |
|
|
174 |
|
|
|
15 |
|
|
|
— |
|
|
|
15 |
|
Interest expense, net |
|
|
(9 |
) |
|
|
— |
|
|
|
(9 |
) |
|
|
(7 |
) |
|
|
— |
|
|
|
(7 |
) |
Other income (expense), net |
|
|
280 |
|
|
|
258 |
|
|
|
22 |
|
|
|
(12 |
) |
|
|
— |
|
|
|
(12 |
) |
Income (loss) before income taxes |
|
$ |
40,869 |
|
|
$ |
39,554 |
|
|
$ |
1,315 |
|
|
$ |
1,349 |
|
|
$ |
(200 |
) |
|
$ |
1,549 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211115006283/en/
jtivy@lglgroup.com
(407) 298-2000
Source:
FAQ
What are LGL Group's recent financial results for Q3 2021?
How did LGL Group's backlog change in Q3 2021?
What was LGL Group's diluted earnings per share for Q3 2021?
What strategic initiatives is LGL Group pursuing?